D. E. Shaw & Co., Inc. Maxcyte, Inc. Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$3.02 - $5.1 $70,728 - $119,441	-23,420 Reduced 48.21%	25,162 $78,000
Q2 2023 Aug 14, 2023	SELL	$3.69 - $5.35 $65,039 - $94,299	-17,626 Reduced 26.62%	48,582 $222,000
Q1 2023 May 15, 2023	BUY	$4.03 - $5.89 $266,818 - $389,965	66,208 New	66,208 $327,000
Q2 2022 Aug 15, 2022	SELL	$3.59 - $6.81 $161,941 - $307,192	-45,109 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.26 - $10.84 $237,273 - $488,981	45,109 New	45,109 $315,000

118

65M

600

2.7K

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $368M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.